Equity Overview
Price & Market Data
Price: $3.56
Daily Change: $0.00 / 0.00%
Daily Range: $2.76 - $3.60
Market Cap: $155,438,160
Daily Volume: 109,340
Performance Metrics
1 Week: 15.21%
1 Month: -9.64%
3 Months: -22.61%
6 Months: -27.94%
1 Year: -45.23%
YTD: -22.61%
Company Details
Employees: 153
Sector: Health technology
Industry: Medical specialties
Country: Belgium
Details
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.